Authors: FELDHAUS AL EVANS L SUTHERLAND RA JONES LA

Citation: Al. Feldhaus et al., A CD2 CD28 CHIMERIC RECEPTOR TRIGGERS THE CD28 SIGNALING PATHWAY IN CTLL.2 CELLS/, Gene therapy, 4(8), 1997, pp. 833-838

Authors: KWON ED HURWITZ AA FOSTER BA MADIAS C FELDHAUS AL GREENBERG NM BURG MB ALLISON JP

Citation: Ed. Kwon et al., MANIPULATION OF T-CELL COSTIMULATORY AND INHIBITORY SIGNALS FOR IMMUNOTHERAPY OF PROSTATE-CANCER, Proceedings of the National Academy of Sciences of the United Statesof America, 94(15), 1997, pp. 8099-8103

Authors: LUPTON SD ALLEN JM FELDHAUS AL FLYER DC HENDERSON RA HENNEN KB PORTER LJ SAUND NK SUTHERLAND A WIETIESCLARY KM WITTE PR

Citation: Sd. Lupton et al., ADOPTIVE IMMUNOTHERAPY OF MALIGNANT DISEASES USING GENE-MODIFIED TUMOR-SPECIFIC CD8-LYMPHOCYTES( CYTOTOXIC T), Journal of cellular biochemistry, 1994, pp. 115-115

Authors: ZIEGLER SF LEVIN SD JOHNSON L COPELAND NG GILBERT DJ JENKINS NA BAKER E SUTHERLAND GR FELDHAUS AL RAMSDELL F

Citation: Sf. Ziegler et al., THE MOUSE CD69 GENE - STRUCTURE, EXPRESSION, AND MAPPING TO THE NK GENE-COMPLEX, The Journal of immunology, 152(3), 1994, pp. 1228-1236

Authors: FELDHAUS AL KLUG CA ARVIN KL SINGH H

Citation: Al. Feldhaus et al., TARGETED DISRUPTION OF THE OCT-2 LOCUS IN A B-CELL PROVIDES GENETIC-EVIDENCE FOR 2-DISTINCT CELL-TYPE-SPECIFIC PATHWAYS OF OCTAMER ELEMENT-MEDIATED GENE ACTIVATION, EMBO journal, 12(7), 1993, pp. 2763-2772

Authors: HENDERSON RA ALLEN JM FELDHAUS AL FLYER DC HENNEN KB PORTER LJ SAUND NK WITTE PR LUPTON SD

Citation: Ra. Henderson et al., ADOPTIVE IMMUNOTHERAPY OF MALIGNANCIES EXPRESSING NOVEL FUSION PROTEINS USING GENE MODIFIED CYTOTOXIC T-LYMPHOCYTES, Blood, 82(10), 1993, pp. 10000582-10000582